Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190